SG11201401322UA - Ethynyl derivatives as mglur5 allosteric modulators - Google Patents
Ethynyl derivatives as mglur5 allosteric modulatorsInfo
- Publication number
- SG11201401322UA SG11201401322UA SG11201401322UA SG11201401322UA SG11201401322UA SG 11201401322U A SG11201401322U A SG 11201401322UA SG 11201401322U A SG11201401322U A SG 11201401322UA SG 11201401322U A SG11201401322U A SG 11201401322UA SG 11201401322U A SG11201401322U A SG 11201401322UA
- Authority
- SG
- Singapore
- Prior art keywords
- allosteric modulators
- ethynyl derivatives
- mglur5 allosteric
- mglur5
- ethynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11184331 | 2011-10-07 | ||
PCT/EP2012/069599 WO2013050454A1 (en) | 2011-10-07 | 2012-10-04 | Ethynyl derivatives as mglur5 allosteric modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201401322UA true SG11201401322UA (en) | 2014-09-26 |
Family
ID=46968237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201401322UA SG11201401322UA (en) | 2011-10-07 | 2012-10-04 | Ethynyl derivatives as mglur5 allosteric modulators |
Country Status (26)
Country | Link |
---|---|
US (1) | US8969338B2 (en) |
EP (1) | EP2763977B1 (en) |
JP (1) | JP5840793B2 (en) |
KR (1) | KR101637792B1 (en) |
CN (1) | CN103857668B (en) |
AR (1) | AR088246A1 (en) |
AU (1) | AU2012320598B2 (en) |
BR (1) | BR112014007898A2 (en) |
CA (1) | CA2850082C (en) |
CL (1) | CL2014000819A1 (en) |
CO (1) | CO6900143A2 (en) |
CR (1) | CR20140094A (en) |
EA (1) | EA024973B1 (en) |
EC (1) | ECSP14013296A (en) |
ES (1) | ES2564884T3 (en) |
HK (1) | HK1195298A1 (en) |
IL (1) | IL231783A (en) |
IN (1) | IN2014CN02478A (en) |
MX (1) | MX360667B (en) |
MY (1) | MY170822A (en) |
PE (1) | PE20141556A1 (en) |
SG (1) | SG11201401322UA (en) |
TW (1) | TWI468401B (en) |
UA (1) | UA110862C2 (en) |
WO (1) | WO2013050454A1 (en) |
ZA (1) | ZA201402069B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
UA113223C2 (en) * | 2012-08-13 | 2016-12-26 | ARYLETINYLPYRIMIDINE | |
ES2599507T3 (en) * | 2012-10-18 | 2017-02-02 | F. Hoffmann-La Roche Ag | Ethinyl derivatives as modulators of mGluR5 receptor activity |
UA116023C2 (en) * | 2013-07-08 | 2018-01-25 | Ф. Хоффманн-Ля Рош Аг | Ethynyl derivatives as metabotropic glutamate receptor antagonists |
MX370341B (en) * | 2013-09-25 | 2019-12-10 | Hoffmann La Roche | Ethynyl derivatives. |
HUE048867T2 (en) | 2015-06-03 | 2020-08-28 | Hoffmann La Roche | Ethynyl derivatives |
KR20180026438A (en) | 2015-07-15 | 2018-03-12 | 에프. 호프만-라 로슈 아게 | Ethynyl derivatives as metabotropic glutamate receptor modulators |
CN106632243B (en) * | 2015-10-28 | 2019-03-15 | 华领医药技术(上海)有限公司 | Pyrrolidin derivatives |
ES2826389T3 (en) | 2016-07-18 | 2021-05-18 | Hoffmann La Roche | Ethinyl derivatives |
CN111032659B (en) * | 2017-08-17 | 2022-09-09 | 豪夫迈·罗氏有限公司 | Imidazo [1, 2-a ] imidazol-2-one derivatives for the treatment of diseases such as parkinson's disease |
TW202239407A (en) | 2020-12-17 | 2022-10-16 | 瑞典商阿斯特捷利康公司 | N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3213780B2 (en) | 1993-12-21 | 2001-10-02 | キヤノン株式会社 | Optically active compound, liquid crystal composition containing the same, liquid crystal element using the liquid crystal composition, display method and display device using the same |
JPH09151179A (en) | 1995-11-30 | 1997-06-10 | Canon Inc | Optically active compound, liquid crystal composition containing the same, liquid crystal element having the composition, liquid crystal apparatus and displaying method using them |
US6410728B1 (en) | 2000-08-31 | 2002-06-25 | Abbott Laboratories | Oxazolidinone chemotherapeutic agents |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
WO2006048771A1 (en) | 2004-11-04 | 2006-05-11 | Addex Pharmaceuticals Sa | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
MX2009013169A (en) * | 2007-06-03 | 2010-04-30 | Univ Vanderbilt | Benzamide mglur5 positive allosteric modulators and methods of making and using same. |
US8389536B2 (en) | 2009-10-27 | 2013-03-05 | Hoffmann-La Roche Inc. | Positive allosteric modulators (PAM) |
US8586581B2 (en) * | 2009-12-17 | 2013-11-19 | Hoffmann-La Roche Inc | Ethynyl compounds useful for treatment of CNS disorders |
US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
US8772300B2 (en) * | 2011-04-19 | 2014-07-08 | Hoffmann-La Roche Inc. | Phenyl or pyridinyl-ethynyl derivatives |
AU2012247653B2 (en) * | 2011-04-26 | 2016-05-26 | F. Hoffmann-La Roche Ag | Ethynyl derivatives as positive allosteric modulators of the mGluR5 |
SG194095A1 (en) * | 2011-04-26 | 2013-11-29 | Hoffmann La Roche | Pyrazolidin-3-one derivatives |
-
2012
- 2012-04-10 UA UAA201404621A patent/UA110862C2/en unknown
- 2012-09-27 US US13/628,136 patent/US8969338B2/en active Active
- 2012-10-04 PE PE2014000496A patent/PE20141556A1/en active IP Right Grant
- 2012-10-04 SG SG11201401322UA patent/SG11201401322UA/en unknown
- 2012-10-04 AU AU2012320598A patent/AU2012320598B2/en not_active Ceased
- 2012-10-04 ES ES12767005.7T patent/ES2564884T3/en active Active
- 2012-10-04 IN IN2478CHN2014 patent/IN2014CN02478A/en unknown
- 2012-10-04 CN CN201280049430.1A patent/CN103857668B/en active Active
- 2012-10-04 MY MYPI2014001004A patent/MY170822A/en unknown
- 2012-10-04 BR BR112014007898A patent/BR112014007898A2/en not_active IP Right Cessation
- 2012-10-04 KR KR1020147011355A patent/KR101637792B1/en active IP Right Grant
- 2012-10-04 EP EP12767005.7A patent/EP2763977B1/en active Active
- 2012-10-04 TW TW101136749A patent/TWI468401B/en not_active IP Right Cessation
- 2012-10-04 JP JP2014533884A patent/JP5840793B2/en active Active
- 2012-10-04 CA CA2850082A patent/CA2850082C/en not_active Expired - Fee Related
- 2012-10-04 EA EA201490722A patent/EA024973B1/en not_active IP Right Cessation
- 2012-10-04 WO PCT/EP2012/069599 patent/WO2013050454A1/en active Application Filing
- 2012-10-04 MX MX2014004144A patent/MX360667B/en active IP Right Grant
- 2012-10-05 AR ARP120103716A patent/AR088246A1/en unknown
-
2014
- 2014-02-26 CR CR20140094A patent/CR20140094A/en unknown
- 2014-02-28 CO CO14043450A patent/CO6900143A2/en active IP Right Grant
- 2014-03-20 ZA ZA2014/02069A patent/ZA201402069B/en unknown
- 2014-03-27 IL IL231783A patent/IL231783A/en active IP Right Grant
- 2014-04-03 CL CL2014000819A patent/CL2014000819A1/en unknown
- 2014-04-07 EC ECSP14013296 patent/ECSP14013296A/en unknown
- 2014-07-08 HK HK14106907.3A patent/HK1195298A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201306175B (en) | Isoxazole derivatives | |
SG10201601802YA (en) | Dispiropyrrolidine derivatives | |
ZA201305826B (en) | Substituted amminobutyric derivatives as neprilysin inhibitors | |
HK1195298A1 (en) | Ethynyl derivatives as mglur5 allosteric modulators mglur5 | |
IL227664A0 (en) | Novel heterocyclic derivatives | |
ZA201401884B (en) | New dihydroquinoline-2-one derivatives | |
IL247639B (en) | Heteroarylpiperidine derivatives | |
HK1191330A1 (en) | Ethynyl derivatives as positive allosteric modulators of the mglur5 mglur5 | |
EP2709609A4 (en) | Heterocyclic compounds | |
IL231950B (en) | Aryl-quinoline derivatives | |
EP2721029A4 (en) | Imidazopyridin-2-one derivatives | |
EP2793580A4 (en) | Novel iso-ergoline derivatives | |
SI2766342T1 (en) | Phenyl-guanidine derivatives | |
ZA201308049B (en) | 3-ureidoisoquinolin-8-yl derivatives | |
EP2769720A4 (en) | Heterocyclic gsk-3 allosteric modulators | |
ZA201209319B (en) | Cyclopropyl-indole derivatives |